Trump’s F.D.A. Pick Could Undo Decades of Drug Safeguards

A top candidate to head the agency, Jim O’Neill, advocates “progressive” approval, in which drugs proved safe could be sold to consumers even if not yet proved effective.

from NYT > Health http://ift.tt/2kvSr3R
via health&fitness